Rituximab plus /- ibrutinib as first line therapy for marginal zone lymphoma Meeting Abstract
| Authors: | Noy, A.; Thet, W. S.; Vemuri, S.; Seshan, V.; Batlevi, C. L.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Habermann, T. M.; Hamlin, P. A.; Joffe, E.; Lue, J. K.; Matasar, M.; Palomba, M. L.; Zelenetz, A. D.; Salles, G. |
| Abstract Title: | Rituximab plus /- ibrutinib as first line therapy for marginal zone lymphoma |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 6352 |
| Language: | English |
| ACCESSION: | WOS:001412809000026 |
| DOI: | 10.1182/blood-2024-211730 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
